Clinical Trial Update: A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating an immunomodulatory therapy for adults with perennial allergic rhinoconjunctivitis (including house dust mite allergy) has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• House Dust Mite Allergy
• Perennial Allergic Rhinoconjunctivitis

Drugs mentioned

• Immunomodulatory Therapy

Snippet

Sponsor: Cytos Biotechnology AG | Conditions: Perennial Allergic Rhinoconjunctivitis, House Dust Mite Allergy | Phase 2 | Status: COMPLETED